Related Experiment Videos
Fabry disease--a diagnostic and therapeutic problem.
Branka Jeren Strujić1, Tatjana Jeren
1Department of Internal Medicine, Dubrava University Hospital, Zagreb, Croatia. bfm@bfm.hr
Renal Failure
|December 15, 2005
Summary
Fabry syndrome, a genetic disorder, often presents with diverse symptoms leading to delayed diagnosis. Early detection and enzyme replacement therapy are crucial for managing this complex condition.
Area of Science:
- Genetics
- Biochemistry
- Internal Medicine
Background:
- Fabry syndrome is an X-linked genetic disorder caused by deficient alpha-galactosidase enzyme activity.
- This deficiency leads to the accumulation of globotriaosylceramide, resulting in multi-organ damage.
Observation:
- The case highlights a patient with Fabry syndrome experiencing delayed diagnosis due to complex and diverse symptomatology.
- Key clinical manifestations included generalized vasculopathy, left ventricular hypertrophy, and central nervous system involvement.
- Nonspecific renal symptoms like proteinuria and microhematuria prompted further investigation.
Findings:
- Significantly decreased alpha-galactosidase levels confirmed the diagnosis.
- The patient's presentation exemplified the typical, albeit complex, clinical picture of Fabry disease.
- Vasculopathy was identified as a primary driver of multiorgan complications.
Implications:
- This case underscores the importance of recognizing varied clinical presentations for timely Fabry syndrome diagnosis.
- Successful enrollment in enzyme replacement therapy offers a promising treatment avenue.
- Further research into enzyme synthesis and targeted therapies is warranted for improved patient outcomes.